The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers
Clinical trial NCT01022333 · UNKNOWN
Trial details
- NCT number
- NCT01022333
- Sponsor
- Women's College Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2010-07-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.